SD HEALTHCARE
Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Ionis Pharmaceuticals to Acquire Remaining Stake in Akcea
BIOTECH: Boston Co. Was Spun Out of Ionis, Had IPO in 2017
Ionis Pharmaceuticals plans to acquire the remaining stake in Akcea Therapeutics that it does not already own for approximately $500 million cash.
Aegis Life Using Its Technology to Develop DNA-Focused COVID-19 Vaccine
BIOTECH: Company Received $4.2M in Grant Funding
San Diego-based Aegis Life, a biotechnology company developing vaccines and therapies for life-threatening diseases, has entered the race to combat COVID-19 with its DNA vaccine.
Working to Erase Cancer
BIOTECH: Erasca Raises $236 Million
Erasca, a cancer therapeutics company seeking to eliminate cancer, has completed a $36 million extension of its Series B financing round, bringing its total Series B round to $236 million.
La Jolla Institute Gets $6.4M for COVID Research
BIOTECH: Investigations to Focus on Understudied Part of Antibody
The National Institute of Allergy and Infectious Diseases, one of the National Institutes of Health, has awarded more than $6.4 million to Erica Ollmann Saphire, Ph.D., a professor at the La Jolla Institute for Immunology, to support research toward COVID-19 antibody therapeutics. The local organization announced the award on Aug. 20.
Inhibrx Gains $125.7M in IPO, Has Cancer in its Sights
BIOTECH: Firm Uses Protein Engineering to Develop Drug Candidates
Inhibrx Inc. completed its initial public offering on Aug. 20, gaining an estimated $125.7 million to push its business forward.
San Ysidro Health Front-Line Staff Receives Donation of Meals from Frontline Foods
On Wednesday, Aug. 26, 2020, several San Ysidro Health rural clinics in East County received a donation of meals for the organization’s front line staff from Frontline Foods as a thank you for their fearless dedication during this pandemic.
Diomics Developing Test to Reveal SARS-CoV-2 Antibodies
Diomics, a San Diego-based biotech company, announced on Aug. 19 that it is developing the Diocheck Antibody Indicator, which provides a simple way for individuals to monitor for the presence of antibodies to SARS-CoV-2 over an extended period of time.
Carlsbad Co. Uses RFID to Better Manage Inventory
TECH: Designs, Manufactures Healthcare Supply Chain Solutions
Ligand Inks $516M Deal
BIOTECH: Agrees To Purchase Pfenex
Kaiser Permanente Opens Next Generation Medical Building in Clairemont Mesa
HEALTHCARE: Facility Designed to Give Members ‘Positive Experience’
Runway Growth Expands to San Diego
INVESTMENT: Firm Aims to Deploy Capital to Life Science Companies
Carlsbad Medtech Firm Finds Success with IPO
Company Raises $183Million in Offering Last Week
COVID-19 Test in Demand
BIOTECH: Hologic On Track to Double Its Factory Capacity
Evofem Reports Results, Readies Product For September Debut
PHARMACEUTICALS: FDA Approved New Form of Birth Control in May
ProciseDx Raises $10.5M In Series A
BIOTECH: Co. Making Progress in Gastrointestinal Tests
Prev Next